Ryanodine receptors (RyRs) are the Ca 2+ release channels in the sarcoplasmic reticulum in striated muscle which play an important role in excitation-contraction coupling and cardiac pacemaking. Single channel recordings have revealed a wealth of information about ligand regulation of RyRs from mammalian skeletal and cardiac muscle (RyR1 and RyR2, respectively). RyR subunit has a Ca 2+ activation site located in the luminal and cytoplasmic domains of the RyR. These sites synergistically feed into a common gating mechanism for channel activation by luminal and cytoplasmic Ca 2+ . RyRs also possess two inhibitory sites in their cytoplasmic domains with Ca 2+ affinities of the order of 1 μM and 1 mM. Magnesium competes with Ca 2+ at these sites to inhibit RyRs and this plays an important role in modulating their Ca 2+ -dependent activity in muscle. This review focuses on how these sites lead to RyR modulation by Ca 2+ and Mg 2+ and how these mechanisms control Ca 2+ release in excitationcontraction coupling and cardiac pacemaking.
Introduction
Muscle contracts in response to the electrical excitation of the surface membrane by a process called excitation-contraction (E-C) coupling whereby surface membrane depolarisation elicits calcium release from the sarcoplasmic reticulum (SR). The SR is the primary intracellular Ca 2+ store and ryanodine receptors (RyR) are the Ca 2+ release channels. Three RyR isoforms have been identified in mammals: RyR1 in skeletal muscle, RyR2 in cardiac and smooth muscle and RyR3 in many cell types (Ogawa 1994) . Regulation of RyRs by intracellular Ca 2+ and Mg 2+ (Coronado et al. 1994 ; Meissner 1994) plays a major role in how the cell controls SR Ca 2+ release. Single channel recordings have revealed a wealth of information about Ca 2+ and Mg 2+ regulation of RyR and have gone a long way to untangling their many interdependent RyR gating mechanisms. This article reviews the current general picture of RyR regulation by Ca 2+ and Mg
2+
. A detailed review of functional models of RyR2 gating by Ca 2+ and Mg 2+ has been given elsewhere (Laver 2010).
RyR2 activation by cytoplasmic and luminal Ca 2+
Both RyR1 (Hymel et al. 1988; Smith et al. 1986 ) and RyR2 isoforms (Meissner et al. 1986 ) exhibit activation by micrometre concentrations of cytoplasmic Ca 2+ . In the absence of any other channel activator, cytoplasmic Ca 2+ can increase channel open probability (P o ) from virtually zero up to P o~0 .6 with a half-maximal activation concentration (K a ) of 1-5 μM (Laver et al. 1995; Sitsapesan and Williams 1994a; Xu et al. 1996) . RyR2 was shown to have a steep P o dependence on cytoplasmic [Ca 2+ ], typically exhibiting Hill coefficients of 2-4 (Sitsapesan and Williams 1994a) as would be expected if RyR2 activation resulted from cooperative involvement of one high-affinity (~1 μM) Ca 2+ binding site on each subunit of the homotetrameric channel (Zahradnik et al. 2005) . The cytoplasmic Ca 2+ activation site is referred to here as the A-site, a name originally coined by Balog et al. (2001) (A for Activation).
Early studies gained clues to the distance of the A-sites from the channel pore from their sensitivity to Ca 2+ flowing from the luminal side of the membrane into a cytoplasmic milieu containing a fast Ca 2+ chelator such as BAPTA (Laver 2007; Tripathy and Meissner 1996) . The dilution and sequestering of Ca 2+ emanating from the pore creates a concentration gradient such that the [Ca 2+ ] at the A-site will depend on its distance from the pore. Analytic solutions of the Ca 2+ diffusion/buffering equations (Bers and Peskoff 1991) predicted a distance of 11 nm between the A-site and the cytoplasmic pore mouth. More recent mutagenesis experiments revealed that the RyR1 mutation, E4032A and the corresponding mutation E3987A in RyR2 impeded channel activation by~1000-fold, implicating this amino acid with the A-site (Fessenden et al. 2001; Li and Chen 2001) . Recently, cryo-EM reconstructions of RyR1 identified the A-site Ca 2+ binding pocket near, but not including, E4032. It is formed by the carboxylate side chains of E3893 and E3967 of the RyR1 core solenoid and the backbone carbonyl of T5001 in the Cterminal domain (des Georges et al. 2016) . The approximate location of the A-site is shown in a RyR1 gating domain schematic in Fig. 1 . Interestingly, the location of the site is~9 nm from the pore gate, consistent with estimates from diffusion/ chelation experiments (Laver 2007; Tripathy and Meissner 1996) ] from 1 to 100 nM increased luminal Ca 2+ activation by 4-fold without altering the apparent affinity of the L-site. Likewise, increasing luminal [Ca 2+ ] from 1 nM to 0.1 mM increased cytoplasmic Ca 2+ activation without altering the apparent affinity of the A-site. Therefore, Ca 2+ activation is not uniquely attributable to either the A-or L-sites but rather is a combination of both. However, this synergy was only apparent at cytoplasmic [Ca 2+ ] lower than 10 μM. At higher concentrations, the RyR opening rate is insensitive to luminal [Ca 2+ ]. This synergy between A-and L-sites is also apparent in mutagenesis studies (Chen et al. 2014) where loss of either A-or L-site activation was always accompanied by partial loss of activation (opening rate) by the other site.
Cytoplasmic Ca 2+ inhibition of RyR1 and RyR2
Millimolar cytoplasmic [Ca 2+ ] inhibits RyR1 (Bezprozvanny et al. 1991; Meissner 1986) and RyR2 (Laver et al. 1995 (Chen et al. 2014) inhibitory sites on the RyR. RyR2 is 10-fold less sensitive to Ca 2+ inhibition than RyR1 (Laver et al. 1995) . In keeping with the nomenclature of Balog et al. (2001) , this site is referred to here as the I1-site (I for inhibition and I1 to distinguish it from a recently identified high-affinity inhibition site, I2-site, see below). At physiological concentrations of monovalent ions, the apparent Ca 2+ affinity of the I1-site in RyR1 was 100 μM and this increased as the 2nd power of monovalent ion concentration (Meissner et al. 1997; Shomer et al. 1993) . Together, the A-and I1-sites generate the well-known, bellshaped cytoplasmic [Ca 2+ ] dependence of P o which characterises RyR activation at micrometre Ca 2+ and inhibition at millimolar Ca
2+
. Since Ca 2+ levels in the bulk cytoplasm only reach~1 μM (Bers 2002c) , this process was originally not seen as physiologically important (Bezprozvanny et al. 1991) . Even taking into account the much higher levels of Ca 2+ in the triadic cleft (200 μM (Soeller and Cannell 1997)), Mg 2+ inhibition by the I1-site will be more significant to muscle function than Ca 2+ inhibition (see below). The location of the I1-site has not yet been determined in cryo-EM reconstructions. Mutated RyR1, which lacked amino acids 1641-2437 in the so-called junctional solenoid domain (des Georges et al. 2016) or Handle domain (Peng et al. 2016) , required 10-fold higher Ca 2+ than wt-RyR1 for inhibition but still had normal Ca 2+ activation (Bhat et al. 1997) . It has been noted (Laver et al. 1997b ) that within this region of RyR1 is a distinctive sequence of 30 negative amino acids at positions 1873-1903, whereas in the corresponding region in RyR2 has far fewer negative amino acids. These would create a diffuse electrostatic binding region consistent with a low-affinity binding site that produces equal inhibition by Ca 2+ and Mg 2+ (Mg 2+ is reviewed below). Also, the reduced negative charge in the corresponding region in RyR2 might explain their lower sensitivity Ca 2+ inhibition. Another cytoplasmic Ca 2+ inhibition phenomenon has been identified in single channel recordings of RyR2 which has been attributed to a high-affinity, cytoplasmic facing site (I2-site) (Laver 2007). It is manifest as a cytoplasmic [Ca 2+ ]-dependent reduction in channel open time in the sub micrometre range. Ca 2+ diffusion/buffering experiments (described above for the A-site) estimate a 26-nm distance between the I2-site and the cytoplasmic mouth of the channel, somewhat further away than the A-site (Laver 2007). As yet, the physiological significance and precise location of this site are unknown.
Mg

2+ inhibition of RyR1 and RyR2
Mg 2+ is a strong inhibitor of RyRs that acts as a competitive Ca 2+ antagonist at the A-site (Smith et al. 1986 ) with a binding affinity of~50 μM (Laver and Honen 2008; Meissner et al. 1986; Meissner and Henderson 1987 (Laver et al. 1997a) . This finding provided an explanation for the physiological significance of the I1-site in skeletal muscle where the IC 50 for the I1-site is~0.1 mM. Even though physiological concentrations of Ca 2+ are well below the IC 50 , Mg 2+ levels are 10-fold higher than this and will strongly inhibit RyR1 in the cell. However, in RyR2, the IC 50 of the I1-site is~10 mM so it is unlikely that intracellular Mg 2+ will have a sufficient inhibitory action at this site to make it a significant regulator in the heart.
Luminal , the K a lies within the physiological range will have a substantial effect on RyR2 activity and Ca 2+ release.
RyR1 regulation during excitation-contraction coupling in skeletal muscle
In striated muscle, the L-type Ca 2+ channels (DHPRs) located in the sarcolemma and transverse tubules are the voltage sensor. In skeletal muscle, the DHPRs directly interact with RyR1 and their depolarisation by an action potential induces conformational changes that are relayed to RyR1 to cause it to open (Tanabe et al. 1990 1994) . Though the particular Mg 2+ inhibition mechanism being modulated has not been determined, it would need to involve the I1-site for it to be effective in de-repressing RyR1.
ATP can substantially activate RyR1 even when cytoplasmic [Ca 2+ ] is at resting levels (~100 nM). This explains why RyR1 can be opened without there being any influx of extracellular Ca 2+ to act as a trigger. Therefore, in resting muscle, RyR1 is primed for activation and once the activation of DHPRs alleviates Mg 2+ inhibition, the RyR1 will open. Removal of ATP stimulation of RyR1 'deprimes' RyR1 resulting in a loss of E-C coupling, i.e. the E-C coupling mechanism in skeletal muscle absolutely requires upregulation of RyR1 by ATP (Blazev and Lamb 1999a, 1999b (Cannell et al. 2013; Laver et al. 2013) , by a mechanism called 'induction decay' (Laver et al. 2013) . In this process, depletion of the junctional SR leads to a decay of CICR and subsequent deactivation of RyR2. The junctional SR depleted by9 0% with virtually no depletion of the longitudinal SR due to the limited connection between the two SR compartments. Model simulations of confocal images revealed that the inability of confocal microscopes to resolve fluo-5N fluorescence in junctional and longitudinal SR leads to an underestimation of junctional SR depletion and so reconciled model and experimental estimates of SR depletion. Experimental support for the idea of 'induction decay' came from the observation that reducing RyR2 conductance increased the rate of Ca 2+ spark termination (Guo et al. 2012 ).
RyR2 regulation during cardiac pacemaking
In cardiomyocytes, SERCA2a and RyR2 carry Ca 2+ uptake and release, respectively, across the SR membrane while DHPRs and Na/Ca exchangers (NCXs) carry Ca 2+ uptake and release across the sarcolemma, respectively (Dibb et al. 2007 ). These transporters generate the large oscillations in free [Ca 2+ ] in the cytoplasm ([Ca 2+ ]~0.1 to 1 μM) and SR lumen ([Ca 2+ ]~1 to 0.3 mM) between diastole and systole, respectively (Bers 2002b (Bers 2002a ). This process was first shown to generate a 'clock cycle' that could entrain pacemaker action potentials in lymphatic smooth muscle (Van Helden 1993) and more recently in cardiac pacemaking in the sinoatrial node (Ju and Allen 1998; Ju and Allen 2007; Lakatta and DiFrancesco 2009; Rigg and Terrar 1996) . Although this process depends on many ion transport and buffering mechanisms (Bers 2002a) (Jiang et al. 2005) ). Second, during Ca 2+ release, CICR provides positive reinforcement of RyR2 activity via the A-site which continues until the SR lumen depletes and the decaying CICR can no longer support RyR2 activation and RyR2 close. Subsequently, the SR reloads and the cycle is repeated, producing a cyclic, bistable oscillation analogous to the motion of a tipping urn (Fig. 2) Fig. 2 Two schematics illustrating how SERCA2a and RyR2 produce cycling of Ca 2+ uptake and release in cardiac SR. The left shows an idealised SR with SERCA2a driven uptake and RyR2-mediated release which is controlled by luminal and cytoplasmic facing Ca 2+ activation sites (L-sites-red; A-sites-blue). Store filling with Ca 2+ is signified by dark blue. As the store fills (middle left), the L-sites trigger the opening of RyR2 (bottom left) and the resulting Ca 2+ flow to the A-sites reinforce channel opening until the stores are nearly depleted SERCA2a (top left). The right side shows the analogy of a 'tipping urn' that undergoes bistable oscillations by similar mechanisms. The thick arrows indicate water flow. Analogous features are (1) SERCA2a transport rate and water flow rate; (2) SR capacity and urn capacity; and (3) effective Ca 2+ affinity of the L-site and the pivot point depolarization of the sarcolemma (i.e. 3 Na + enter for every Ca 2+ extruded) and enhanced sarcolemmal excitability with the effect of entraining pacemaker action potentials (Bers 2002a ).
An example of how this would work within a physiological setting is the case of the sympathetic 'fight or flight' response that increases heart rate and contractility. Increased catecholamine concentrations stimulate cardiac β-adrenergic receptors (β-AR), resulting in phosphorylation and increased activity of key Ca 2+ transporters including SERCA2a and RyR2 (Bers 2002b) . Many studies have demonstrated increased phosphorylation of RyR2 at S2808, S2814 and S2030 (Benkusky et al. 2007; Carter et al. 2006; Currie et al. 2004; Ferrero et al. 2007; Huke and Bers 2008; Li et al. 2013; Rodriguez et al. 2003; Xiao et al. 2006) . Detailed analysis of RyR2 regulation of channels isolated from adrenergic-stimulated hearts showed that adrenergic stimulation increased their L-site-mediated luminal Ca 2+ activation without affecting A-site RyR2 activation (Li et al. 2013) . Such an increase in L-site sensitivity would cause earlier onset of the Ca 2+ release phase in the cardiac cycle which would increase Ca 2+ cycling rate and so provide a driver for increasing pacemaking frequency.
Concluding remarks
Thus far, four Ca 2+ regulation sites have been identified in RyRs. They have two Ca 2+ activation sites located in the luminal and cytoplasmic domains of the RyR (L-and A-sites). These sites feed into a common gating mechanism and produce synergistic activation by luminal and cytoplasmic Ca 2+ . The cytoplasmic domains also possess two inhibitory sites (I1-and I2-sites) with Ca 2+ affinities of the order of millimolar and micromolar, respectively. Magnesium competes with Ca 2+ at these sites and plays an important role in inhibiting RyRs and shaping the Ca 2+ -dependent activation of RyRs in muscle. Recent analysis of RyR1 structure has identified one A-site in each subunit at the interfaces between the C-terminal domain and the core solenoid, at a distance from the cytoplasmic pore mouth that was predicted by functional studies.
RyR2 and RyR1 share common Ca 2+ /Mg 2+ regulation mechanisms albeit with different sensitivities and these differences lead to quite different types of cellular control over SR Ca 2+ release in skeletal and cardiac muscle (Lamb 2000; Laver et al. 2001) . In resting skeletal muscle, RyR1 would be activated by ATP if it were not for Mg 2+ which strongly inhibits the channels via the I1-site. 
